Concord Medical Services Holdings Ltd - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Concord Medical Services Holdings Limited (NYSE: CCM) covers the month of May 2025, with a specific announcement date of May 13, 2025. The filing reports on a shareholding increase by a controlling shareholder of Concord Healthcare Group Co., Ltd., a subsidiary of the Company listed on the Hong Kong Stock Exchange (HKSE) under stock code 2453.HK.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on a corporate transaction regarding share ownership.
Material Changes
The primary material change reported is the acquisition of additional shares in Concord Healthcare by Shanghai Medstar Enterprise Management Co., LTD, a subsidiary of the Company. On May 12, 2025, Shanghai Medstar purchased 95,400 H shares from the open market. This transaction follows a previous purchase on May 7, 2025. The May 12 purchase represents approximately 0.01% of the total issued shares of Concord Healthcare.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, specific risks, contingencies, or unusual items. It serves strictly as a disclosure of the share transaction details.
Key Facts for Investor Verification
- Shanghai Medstar purchased 95,400 H shares of Concord Healthcare on May 12, 2025.
- The transaction represents approximately 0.01% of Concord Healthcare's total issued shares.
- Concord Healthcare is a subsidiary of Concord Medical Services Holdings Limited and is listed on the HKSE (2453.HK).
- Further transaction details are available via the HKSE website (www.hkexnews.hk).